• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Model Number RRT07070080L
Device Problem Contamination (1120)
Patient Problem Bacterial Infection (1735)
Event Date 05/14/2019
Event Type  Injury  
Manufacturer Narrative
Analysis-report from third party was received, and will be further investigated.
 
Event Description
It was reported to gore that patient underwent endovascular treatment for a critical limb ischemia with a gore-tex® vascular graft - thin-walled removable ringed.It was stated that the prosthesis was implanted on (b)(6) 2019 as a below-the-knee femoro-popliteal bypass.It was reported that the clinical history takes notes of several revascularizations¿ surgeries in the context of ischemia.It was stated that on (b)(6) 2019, after about 1 month, two segments of the prosthesis were explanted due to infection to staphylococcus méti-s.
 
Manufacturer Narrative
H6 evaluation codes investigation findings 213 refers to the product history review.A review of the manufacturing records indicated the lot met all pre-release specifications.Explant investigation (ei): the following is a summary of the ei observations: tissue present: yes.Segment 1 (19-112): the segment consisted of a gore-tex vascular graft (thin wall removable ring) fragment.The abluminal surface was generally devoid of tissue, except for multi-focal plaques of red/brown tissue.Both extremities were transected.Extremity a was transected in a non-uniform manner, as evident by cross-sectional view.The luminal view presented with dark brown/red and tan tissue occluding the lumen.Extremity b was ovular in shape and the luminal view presented in an unobstructed manner.The luminal patency could not be determined with the images/information provided.Segment 2 (19-113): the segment consisted of a gore-tex vascular graft fragment (type not provided) transected at an angle and connected to a dacron graft (presumptive) via blue running sutures (presumptive prolene®).The blue orientation line was consistent with that of a gore non-stretch vascular graft.The dacron graft was also connected to pink/red/brown native tissue via blue running sutures.The abluminal surface was generally devoid of tissue, except for minimal scattered plaques of red/brown tissue.Dark brown staining was observable on the abluminal surface.A partial, transverse transection, which was closed via blue, monofilament running suture, was present at approximately mid-graft.Multiple areas with evenly spaced serration marks, consistent with grasping/pulling with forceps/clamps, were present around the partial transection on the abluminal surface.Extremity a was transected and ovular in shape and the luminal view presented with brown/red and tan tissue occluding the lumen.The luminal patency could not be determined with the images/information provided.Material disruptions (i.E., transections, forceps marks, running suture) are consistent with those caused by surgical instrumentation (i.E., scalpel/scissors, forceps/clamps, suturing needle) likely used during a surgical procedure.The returned segments could not be correlated to a specific surgical or clinical event, from the information provided.Request for additional analysis: no.Reason: based on the ei¿s review of the third party report and reason for removal (infection), no additional analysis is requested.
 
Manufacturer Narrative
A review of the sterilization records indicated the lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11027049
MDR Text Key222019071
Report Number2017233-2020-01538
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132611034
UDI-Public00733132611034
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K880167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/10/2023
Device Model NumberRRT07070080L
Device Catalogue NumberRRT07070080L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/07/2020
Initial Date FDA Received12/17/2020
Supplement Dates Manufacturer Received10/28/2021
12/07/2021
Supplement Dates FDA Received11/26/2021
12/27/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/11/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient SexMale
-
-